Active Product definition

Active Product means a medical device or system.
Active Product means any Product in [*] Development (i.e., [*] or [*]) or Commercialization.

Examples of Active Product in a sentence

  • Tanox shall be entitled to use and disclose any such information (including any such Company Information) in connection with the Manufacture, Development and Commercialization of any Active Product; subject to Article 15.

  • Such technology transfer agreement shall include a license from Novartis to Manufacture such Active Product under Anti-IgE Patents, Company Information, and Know-How Controlled by Novartis and existing at the effective date of termination which are reasonably required, or to the extent they are used as at the effective date of termination, to Manufacture Active Products.

  • Except as shown on Schedule 8.5 attached hereto, the Inventory of each Active Product shall equal or exceed a two-month supply based upon Seller’s average monthly sales of such Active Products for the last three calendar years.

  • Notwithstanding the foregoing, in no event shall Genentech be obligated to Manufacture a higher volume of Active Product than (i) the reserved manufacturing capacity in the manufacturing facility(ies) of Genentech, its Affiliate(s) or sublicense(s) as set forth in the Manufacturing and Supply Plan, with respect to the ***** of the transition period, and (ii) the average of such manufacturing capacity reserved for the ***** of the transition period, with respect to the ***** of the transition period.

  • The Assignees shall be entitled to use and disclose any such information (including any such Company Information) in connection with the Manufacture, Development and Commercialization of any Active Product; subject to Article 15.

  • Such technology transfer agreement shall include a license from Genentech to Manufacture such Active Product under Anti-IgE Patents, Company Information, and Know-How Controlled by Genentech and existing at the effective date of termination which are reasonably required, or to the extent they are used as at the effective date of termination, to Manufacture Active Products.

  • The warranty and indemnity set forth in Sections 17.1 and 17.2 shall not apply with respect to handling or disposal of Bulk Active, Product, package inserts and other materials used in Manufacturing of Product to the extent that Guilford is responsible therefor pursuant to this Agreement or otherwise, including B▇▇▇▇▇ returns of Bulk Active to Guilford for destruction in accordance with the terms of this Agreement.

  • Without limiting Genentech’s other rights and obligations under this Part 2 of Schedule D, if Genentech is Manufacturing an Active Product on the effective date of termination, it shall continue to comply with its obligations to Manufacture the applicable Active Product under Article 10 herein and the Manufacturing and Supply Agreement(s), unless it provides written notice to Novartis that it does not intend to continue to Manufacture and supply to Novartis such Active Product.

  • Without limiting Novartis’ other rights and obligations under this Part 3 of Schedule D, if Novartis is Manufacturing an Active Product on the effective date of termination, it shall continue to comply with its obligations to Manufacture the applicable Active Product under Article 10 herein and the Manufacturing and Supply Agreement(s), unless it provides written notice to Genentech and Tanox that it does not intend to continue to Manufacture and supply to Novartis such Active Product.

  • Notwithstanding the foregoing, in no event shall Novartis be obligated to Manufacture a higher volume of Active Product than (i) the reserved manufacturing capacity in the manufacturing facility(ies) of Novartis, its Affiliate(s) or sublicense(s) as set forth in the Manufacturing and Supply Plan, with respect to the ***** of the transition period, and (ii) the average of such manufacturing capacity reserved for the ***** of the transition period, with respect to the ***** of the transition period.